全文获取类型
收费全文 | 8730篇 |
免费 | 687篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 103篇 |
儿科学 | 224篇 |
妇产科学 | 229篇 |
基础医学 | 1192篇 |
口腔科学 | 446篇 |
临床医学 | 741篇 |
内科学 | 1907篇 |
皮肤病学 | 192篇 |
神经病学 | 805篇 |
特种医学 | 195篇 |
外国民族医学 | 1篇 |
外科学 | 1426篇 |
综合类 | 51篇 |
一般理论 | 4篇 |
预防医学 | 589篇 |
眼科学 | 116篇 |
药学 | 510篇 |
中国医学 | 24篇 |
肿瘤学 | 706篇 |
出版年
2023年 | 48篇 |
2022年 | 95篇 |
2021年 | 268篇 |
2020年 | 171篇 |
2019年 | 245篇 |
2018年 | 306篇 |
2017年 | 229篇 |
2016年 | 237篇 |
2015年 | 284篇 |
2014年 | 360篇 |
2013年 | 438篇 |
2012年 | 617篇 |
2011年 | 621篇 |
2010年 | 322篇 |
2009年 | 286篇 |
2008年 | 479篇 |
2007年 | 440篇 |
2006年 | 424篇 |
2005年 | 414篇 |
2004年 | 366篇 |
2003年 | 381篇 |
2002年 | 345篇 |
2001年 | 165篇 |
2000年 | 169篇 |
1999年 | 157篇 |
1998年 | 85篇 |
1997年 | 66篇 |
1996年 | 60篇 |
1995年 | 56篇 |
1994年 | 62篇 |
1993年 | 50篇 |
1992年 | 111篇 |
1991年 | 95篇 |
1990年 | 115篇 |
1989年 | 92篇 |
1988年 | 68篇 |
1987年 | 90篇 |
1986年 | 66篇 |
1985年 | 63篇 |
1984年 | 46篇 |
1983年 | 45篇 |
1982年 | 29篇 |
1981年 | 29篇 |
1979年 | 39篇 |
1978年 | 30篇 |
1977年 | 22篇 |
1974年 | 24篇 |
1973年 | 34篇 |
1972年 | 27篇 |
1967年 | 29篇 |
排序方式: 共有9461条查询结果,搜索用时 31 毫秒
1.
2.
Jesus K Yamamoto-Furusho Norma N Parra-Holgu n 《World journal of gastroenterology : WJG》2021,27(48):8242-8261
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years. 相似文献
3.
4.
5.
器官移植术是20世纪出现的针对器官功能衰竭的最有效治疗方法,每年拯救全球超过12万例患者。但供器官短缺的现状,与器官移植技术和辅助药物的发展不匹配,制约了器官移植事业的发展。我国自2015年起已成为全球器官捐献和移植大国之一,2017年公民逝世后器官捐献数量超过5 000例,占全球捐献总量的15%以上。黄洁夫教授总结的器官捐献与移植"中国模式"得到了世界卫生组织、国际移植界的高度重视和充分肯定。本文通过整理全球及各国的器官捐献与移植数据,剖析全球现状与发展趋势,进一步探索我国公民器官捐献的影响因素并提出针对性的应对策略,以期实现我国器官捐献和移植的"自给自足"。 相似文献
6.
Thaís dos Santos Fontes Pereira Carolina Cavalieri Gomes Peter A Brennan Felipe Paiva Fonseca Ricardo Santiago Gomez 《Journal of oral pathology & medicine》2019,48(1):3-9
Fibrous dysplasia is a non‐neoplastic developmental process that affects the craniofacial bones, characterized by painless enlargement as a result of bone substitution by abnormal fibrous tissue. Postzygotic somatic activating mutations in the GNAS1 gene cause fibrous dysplasia and have been extensively investigated, as well as being helpful in the differential diagnosis of the disease. Fibrous dysplasia may involve one (monostotic) or multiple bones (polyostotic), sporadically or in association with McCune‐Albright syndrome, Jeffe‐Lichenstein syndrome, or Mazabreud syndrome. This review summarizes the current knowledge on fibrous dysplasia, emphasizing the value of integrating the understanding of its molecular pathogenesis with the clinical, radiological, and histopathological features. In addition, we address important aspects related to the differential diagnosis and patient management. 相似文献
7.
Rajnish Mago MD John-Paul Gomez MD Namita Gupta MBBS Elisabeth J. S. Kunkel MD 《Current psychiatry reports》2006,8(3):228-233
Anxiety disorders and anxiety symptoms are highly prevalent in the general population and more so in the medically ill. They
have a number of negative consequences for these patients and may worsen the outcome of the medical illness and increase health
care utilization. In the evaluation of these patients, it is of paramount importance to identify the etiology of the anxiety
and, in particular, to differentiate primary from secondary anxiety. Management includes medications (especially benzodiazepines
and selective serotonin reuptake inhibitors) and psychotherapy (particularly cognitive-behavioral therapy). 相似文献
8.
9.
10.
Scarlett Lin Gomez Cynthia D O'Malley Antoinette Stroup Sarah J Shema William A Satariano 《BMC cancer》2007,7(1):193